Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits_老虎社区_美港股上老虎

Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits

Motley Fool2021-06-16

The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

kevinlaisq
·2021-06-16
Oh noooo
回复
点赞
举报
Jeenhow
·2021-06-16
Weed
回复
点赞
举报
Raxon
·2021-06-16
🍖
回复
点赞
举报
KH321
·2021-06-16
Listen to fools.
回复
点赞
举报
Awen1013
·2021-06-16
Buy more
回复
1
举报
Awen1013
·2021-06-16
Buy more
回复
点赞
举报
maddiericola
·2021-06-16
Please like and comment
回复
点赞
举报
收起
- Awen1013:
  Ok
  2021-06-16
  回复
  举报
Ultraviolet
·2021-06-16
Nice
回复
2
举报
收起
- Ultraviolet:
  Fine
  2021-06-16
  回复
  举报
BBBBBBBBBB
·2021-06-16
Ok like n comment pls
回复
6
举报
收起
- Skuah:
  Done
  2021-06-16
  回复
  举报
- J256:
  Done
  2021-06-16
  回复
  举报
- PanaCota:
  ok
  2021-06-16
  回复
  举报
7fbd9d
·2021-06-16
Nice
回复
1
举报
YHho
·2021-06-16
Like
回复
2
举报
tengkianen
·2021-06-16
hank you
回复
1
举报
Mattong
·2021-06-16
Like pls
回复
3
举报
收起
- J256:
  Done
  2021-06-16
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2143428757?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-16 13:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2143428757","market":"us","top_or_hot":-1,"title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","media":"Motley Fool","content":"<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACB","symbol_name":"奥罗拉大麻公司","start_time":0,"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","article_id":"2143428757","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","pubTimestamp":1623822661,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Inefficiency and poor positioning often go hand in hand.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACB":"奥罗拉大麻公司"},"translate_title":"想留着你的钱吗？避免拥有以下三个特征的大麻库存","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACB":0.9},"content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":169823219,"gmtCreate":1623828663131,"gmtModify":1634027461424,"author":{"id":"3572874548548490","authorId":"3572874548548490","name":"kevinlaisq","avatar":"https://static.tigerbbs.com/329de1199f764a89b7cadf50308e183d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572874548548490","authorIdStr":"3572874548548490"},"htmlText":"Oh noooo","listText":"Oh noooo","text":"Oh noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169823219","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169880628,"gmtCreate":1623827342964,"gmtModify":1631892425199,"author":{"id":"3585473275821557","authorId":"3585473275821557","name":"Jeenhow","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3585473275821557","authorIdStr":"3585473275821557"},"htmlText":"Weed","listText":"Weed","text":"Weed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169880628","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169880850,"gmtCreate":1623827330670,"gmtModify":1634027478420,"author":{"id":"3581709463214326","authorId":"3581709463214326","name":"Raxon","avatar":"https://static.tigerbbs.com/f81f6754bb141e86d284b707714fd071","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581709463214326","authorIdStr":"3581709463214326"},"htmlText":"🍖","listText":"🍖","text":"🍖","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169880850","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169817526,"gmtCreate":1623827286765,"gmtModify":1634027478890,"author":{"id":"3586451610703869","authorId":"3586451610703869","name":"KH321","avatar":"https://static.tigerbbs.com/c1bb8bd7d6d5df5f9732871fe60999ea","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586451610703869","authorIdStr":"3586451610703869"},"htmlText":"Listen to fools.&nbsp;","listText":"Listen to fools.&nbsp;","text":"Listen to fools.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169817526","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169836721,"gmtCreate":1623826523063,"gmtModify":1634027487828,"author":{"id":"3575198224041778","authorId":"3575198224041778","name":"Awen1013","avatar":"https://static.tigerbbs.com/eb679e16515f8426f5b874005920a2c6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575198224041778","authorIdStr":"3575198224041778"},"htmlText":"Buy more","listText":"Buy more","text":"Buy more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169836721","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169831674,"gmtCreate":1623826434298,"gmtModify":1634027489957,"author":{"id":"3575198224041778","authorId":"3575198224041778","name":"Awen1013","avatar":"https://static.tigerbbs.com/eb679e16515f8426f5b874005920a2c6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575198224041778","authorIdStr":"3575198224041778"},"htmlText":"Buy more","listText":"Buy more","text":"Buy more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169831674","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169804068,"gmtCreate":1623825401154,"gmtModify":1634027501468,"author":{"id":"3579898276440444","authorId":"3579898276440444","name":"maddiericola","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579898276440444","authorIdStr":"3579898276440444"},"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/169804068","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4804616,"gmtCreate":1623826537134,"gmtModify":1635316884299,"authorId":3575198224041778,"author":{"id":3575198224041778,"idStr":"3575198224041778","authorId":3575198224041778,"name":"Awen1013","avatar":"https://static.tigerbbs.com/eb679e16515f8426f5b874005920a2c6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169804068,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":169170318,"gmtCreate":1623824387634,"gmtModify":1634027515587,"author":{"id":"3580342534451795","authorId":"3580342534451795","name":"Ultraviolet","avatar":"https://static.tigerbbs.com/0a37729d59392a2fd9ac9c4dbe50e826","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3580342534451795","authorIdStr":"3580342534451795"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/169170318","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4804067,"gmtCreate":1623824399443,"gmtModify":1635316932105,"authorId":3580342534451795,"author":{"id":3580342534451795,"idStr":"3580342534451795","authorId":3580342534451795,"name":"Ultraviolet","avatar":"https://static.tigerbbs.com/0a37729d59392a2fd9ac9c4dbe50e826","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169170318,"type":1,"supId":0,"prevId":0,"content":"Fine","text":"Fine","html":"Fine"}],"langContent":"EN"},{"id":169149645,"gmtCreate":1623823793587,"gmtModify":1634027521217,"author":{"id":"3581562365927542","authorId":"3581562365927542","name":"BBBBBBBBBB","avatar":"https://static.tigerbbs.com/973395458d7e1db24dbd4a689c79e8a2","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581562365927542","authorIdStr":"3581562365927542"},"htmlText":"Ok like n comment pls&nbsp;","listText":"Ok like n comment pls&nbsp;","text":"Ok like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/169149645","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4804020,"gmtCreate":1623824188105,"gmtModify":1635316936482,"authorId":3585212912990145,"author":{"id":3585212912990145,"idStr":"3585212912990145","authorId":3585212912990145,"name":"Skuah","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169149645,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":4804313,"gmtCreate":1623825385074,"gmtModify":1635316909554,"authorId":3568246645066934,"author":{"id":3568246645066934,"idStr":"3568246645066934","authorId":3568246645066934,"name":"J256","avatar":"https://static.tigerbbs.com/4c0fb219cf2e82a54daea5531a5407ee","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169149645,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":4813186,"gmtCreate":1623852774509,"gmtModify":1635316172595,"authorId":3581588474178431,"author":{"id":3581588474178431,"idStr":"3581588474178431","authorId":3581588474178431,"name":"PanaCota","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169149645,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":169155201,"gmtCreate":1623823528703,"gmtModify":1634027524037,"author":{"id":"3581578814224856","authorId":"3581578814224856","name":"7fbd9d","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581578814224856","authorIdStr":"3581578814224856"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169155201","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169151410,"gmtCreate":1623823269930,"gmtModify":1634027526929,"author":{"id":"3574655298379922","authorId":"3574655298379922","name":"YHho","avatar":"https://static.tigerbbs.com/2a7ded6d9aa6fc9ede34164a19f1dcb3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574655298379922","authorIdStr":"3574655298379922"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169151410","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169151609,"gmtCreate":1623823258601,"gmtModify":1634027527297,"author":{"id":"3569391399214787","authorId":"3569391399214787","name":"tengkianen","avatar":"https://static.tigerbbs.com/9afe68af4a29c83cb96c1939bb5ab192","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569391399214787","authorIdStr":"3569391399214787"},"htmlText":"hank you","listText":"hank you","text":"hank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169151609","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":169153995,"gmtCreate":1623823202717,"gmtModify":1634027528506,"author":{"id":"3574656676874055","authorId":"3574656676874055","name":"Mattong","avatar":"https://static.tigerbbs.com/8dc1185f7eceb13e12edee09a80365cb","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3574656676874055","authorIdStr":"3574656676874055"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/169153995","repostId":2143428757,"repostType":4,"repost":{"id":"2143428757","pubTimestamp":1623822661,"share":"https://www.laohu8.com/m/news/2143428757?lang=&edition=full","pubTime":"2021-06-16 13:51","market":"us","language":"en","title":"Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits","url":"https://stock-news.laohu8.com/highlight/detail?id=2143428757","media":"Motley Fool","summary":"Inefficiency and poor positioning often go hand in hand.","content":"<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.</p>\n<p>Thankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F630672%2Ftwo-investors-consider-a-stock-with-laptop.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>1. Overbuilt cultivation and manufacturing capacity</h2>\n<p>When cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.</p>\n<p>Time and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when <b>Aurora Cannabis </b>(NASDAQ:ACB) closed <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its facilities and reduced the output of another by 75% late last year.</p>\n<p>As an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.</p>\n<h2>2. Targeting the least lucrative product segments</h2>\n<p>Raw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.</p>\n<p>Furthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's <i>always </i>easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.</p>\n<p>So, it makes sense to avoid companies that focus on selling cannabis flower <i>unless they have proven that they can consistently do so profitably at scale</i>. Be aware that unprofitable companies like Aurora Cannabis and <b>Cronos Group</b> can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.</p>\n<h2>3. Habitual accounting concessions</h2>\n<p>I'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report <i>some</i> financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).</p>\n<p>In short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.</p>\n<p>There's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant to Keep Your Money? Avoid Cannabis Stocks With These 3 Traits\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/06/15/want-to-keep-your-money-avoid-cannabis-stocks-with/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143428757","content_text":"The first step to making money by investing in stocks is to keep the money you already have. That's particularly true when it comes to the marijuana sector, where -- regrettably -- there's an abundance of bad options from which to choose.\nThankfully, the cannabis industry is maturing, but there are already a few common traits among the weakest performers. Aside from general red flags like indebtedness and unprofitability, be sure to pay attention to these three calling cards for cannabis stocks that'll hurt your portfolio's value.\nImage source: Getty Images.\n1. Overbuilt cultivation and manufacturing capacity\nWhen cannabis businesses work to get bigger, it's obvious that they need to have enough marijuana to meet demand. But one of the industry's most common stumbling points is to anticipate more demand than actually exists in the market.\nTime and time again, companies have made massive investments in greenhouses or other cultivation facilities to increase production capacity in anticipation of revenue that never seems to materialize. Then, when the overhead costs become too great a drag on the bottom line for too long, management dolefully announces that the extra capacity needs to be turned off, like when Aurora Cannabis (NASDAQ:ACB) closed one of its facilities and reduced the output of another by 75% late last year.\nAs an investor, it's difficult to judge whether a company's plans to build out new cultivation space are going to be fruitful. Thankfully, you can easily screen out the businesses that have already stumbled by expanding beyond what's supported by demand. If an unprofitable company's cost of goods sold (COGS) eats up a stubbornly high percentage of quarterly revenue, it's a sign there's inefficiency afoot. For example, in the third fiscal quarter of 2021, Aurora Cannabis had a cost of sales of $127.54 million and total net revenue of only $55.16 million. Management attributed this to the detrimental effect of unused capacity.\n2. Targeting the least lucrative product segments\nRaw materials and simple products sell for less per unit than more complex products that require substantial processing. In the cannabis industry, that means products like vaporizers, oils, edibles, skin creams, and beverages have more attractive margins than bulk dried marijuana flower.\nFurthermore, these complex items are less likely to experience competition from illegal products, as they tend to require specialized industrial equipment to make. That doesn't necessarily mean that it's always easier to make a profit on sales of each unit, but it does ensure that competitors will need to spend more up front to purchase the right hardware before they can start to compete for market share.\nSo, it makes sense to avoid companies that focus on selling cannabis flower unless they have proven that they can consistently do so profitably at scale. Be aware that unprofitable companies like Aurora Cannabis and Cronos Group can compete in lucrative segments and still fall victim to low average selling prices. There's a difference between competing in a product segment and deriving a large proportion of total revenue from it.\n3. Habitual accounting concessions\nI'm of the general opinion that the stronger a company's earnings are, the less explanation its financial results need to wow investors. Many cannabis companies are not profitable -- sometimes for reasons management can't control, like changes in the price of bulk cannabis. That means they can't report positive values for their earnings before interest, taxes, depreciation, and amortization (EBITDA), but they still want to report some financial metric that is trending in the right direction. Thus, the concept of \"adjusted\" EBITDA was born (or so I imagine).\nIn short, many marijuana cultivators like Aurora Cannabis and Cronos Group recalculate their EBITDA to account for fluctuations in the market price of cannabis and one-off expenditures, then report the resulting value as adjusted EBITDA.\nThere's nothing wrong with providing alternative metrics for investors to use to evaluate a stock. On the other hand, the healthiest cannabis companies don't need to repackage their earnings results to look appealing, so it's probably good to tread carefully around the ones that do.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4804315,"gmtCreate":1623825391766,"gmtModify":1635316909344,"authorId":3568246645066934,"author":{"id":3568246645066934,"idStr":"3568246645066934","authorId":3568246645066934,"name":"J256","avatar":"https://static.tigerbbs.com/4c0fb219cf2e82a54daea5531a5407ee","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":169153995,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":25,"commentSize":13,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}